IL6 and COVID-19: In diabetic patients with COVID‐19, serum levels of inflammation‐related biomarkers such as IL‐6, C‐reactive protein, serum ferritin, coagulation index and D‐dimer were significantly higher, suggesting that patients with diabetes may be more susceptible to an inflammatory/cytokine storm eventually leading to rapid deterioration of COVID‐19.44